Geneuro
GeNeuro develops innovative treatments against inflammatory and degenerative disorders associated with endogenous retroviruses.
Geneuro has raised €29M across 3 funding rounds, most recently a round in Feb 2024. Based in Geneva, Switzerland; founded 2006; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€29M
€28,500,000
Funding rounds
3
Investors
0
distinct backers
Active since
2020-01
latest 2024-02
Funding by year
EUR raised per yearGeneuro — funding by year — interactive chart.
Data table
| Geneuro — funding by year | |
|---|---|
| 2020 | €18M |
| 2021 | €6.0M |
| 2024 | €5.0M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Down/flat last round
Exit likelihood6
base rate 11% (2+ rounds)
- ▼ Old (20y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-02-06 | Other | €5.0M | — | View deal → |
| 2021-07-16 | Other | €6.0M | — | View deal → |
| 2020-01-31 | Other | €18M | — | View deal → |
Related news
- GeNeuro raises 6 million euros in a private placementstartupticker.ch · 2021-07
- siliconcanals.com
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData